VozehSKewitzGFollathF. Accurate prediction of theophylline serum concentrations using a rapid estimation of theophylline clearance. Clin Pharmacol Ther1980; 27: 291.
5.
PancorboSSawchukRJDasheC. Use of a pharmacokinetic model for individualizing intravenous doses of aminophylline. Eur J Clin Pharmacol1979; 16: 251–4.
6.
SlotfeldtMLJohnsonCEGrambauG. Reliability of theophylline clearance in determining chronic oral dosage regimens. Am J Hosp Pharm1979; 37: 66–8.
7.
WeinbergerMHendelesLBighleyL. The relationship of product formulation to absorption of oral theophylline. N Engl J Med1978; 299: 852–7.
8.
SpanglerDLKalofDDBloomFL. Theophylline bioavailability following oral administration of six sustained-release preparations. Ann Allergy1978; 40: 6–11.
9.
JuskoWJPoliszczukA. High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids. Am J Hosp Pharm1976; 33: 1193–6.
10.
MitenkoPAOgilvieRI. Rational intravenous doses of theophylline. N Engl J Med1973; 289: 600–3.
11.
ZwillichCWSuttonFDNeffTA. Theophylline-induced seizures in adults. Ann Intern Med1975; 82: 784–7.
12.
DastaJMirtalloJMAltmanM. Comparison of standardand sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease. Am J Hosp Pharm1979; 36: 613–7.
13.
WeinbergerMGinchanskyE. Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr1977; 91: 820–4.
14.
LeskoLJ. Dose-dependent elimination kinetics of theophylline. Clin Pharmacokinet1979; 4: 449–59.
